← Back to RDHL

Redhill Biopharma Ltd. - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2022Filed 07/11/2022Jun 2021Filed 07/11/2022Jun 2020Filed 26/08/2021Jun 2019Filed 13/08/2020Jun 2018Filed 23/07/2019Jun 2017Filed 30/08/2018
$18$22$21$1.6$2.4$0.5
−$12−$29−$16−$11−$11−$11
−$0.02−$0.06$0.04$0.04$0.05$0.06

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.